I ۱۳۹۶-۶-۷ ۱۹:۵۱:۲۸ +۰۰:۰۰

Project Description

IDH1 Mutation
IDH2 Mutation
IGH /MAF/WWOX t(14;16)(14q32, 16q23)  for Multiple Myeloma prognosis
IgH gene rearrangement ( Clonality Assay)
IgH gene rearrangement ( MRD Assay as Prognostic Marker )
IgH Gene rearrangement for NHL
IGH/MAFB t(14;20)(14q32,20q12)  for Multiple Myeloma prognosis
IgHV gene mutation – VH 3 &VH 4 ( CLL prognosis) (Sequencing)
IgHV gene mutation – VH1&VH2  ( CLL prognosis) (Sequencing)
IgHV gene mutation – VH5 & VH6 ( CLL prognosis) (Sequencing)
IGK Breakapart for Burkitt Lymphoma / ALL- L3
Igk gene rearrangement ( Clonality Assay)
IgK gene rearrangement for NHL
IGL Breakapart for Burkitt Lymphoma / ALL- L3
Influenza A
Influenza B
Influenza H3N2
Influenza Virous H1N1
Inv(16) or t(16;16);CBFB-MYH11 or CBFB-MYH11/ Inv16